
Cancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday
Quick ReadCancer drugs that speed onto the market based on encouraging preliminary studies often don’t show clear benefits when more careful follow-up trials are done, according to research published Tuesday
Quick ReadThe military is constantly using technology to build better ships, warplanes, guns and armor. Shouldn’t it also use drugs to build better soldiers?
Quick Read
“What’s My Real Identity?”May 22, 2019 |
Someone questioned his Japanese ancestry. So Kim, 34, took out his phone and consulted the 23andMe website. That’s when he discovered his ethnic identity had changed. The site that once told him he was about 40% Japanese now pegged that figure at 5%. He was, in an instant, fully Korean again
Quick ReadOur own bodies. We’ve sent people to space for decades — but we’re only beginning to learn what that means for their health
Quick ReadThe FDA has taken an industry-friendly approach toward companies using unproven cell cocktails to treat people desperate for relief from aging or damaged joints
Quick ReadImagine yourself stuck in the hospital. Would you rather your doctors be well-rested, with a limit on how many hours they can work? Or would you rather they work longer shifts, seeing you through the critical hours of your illness and with fewer handoffs of your care?
Quick Read